Stay tuned for more details!

By sharing real stories, La Fibra Sensible fosters awareness, empathy and mobilization—values we share fully at AROMICS. We stand with patients, families, and all those fighting for visibility, and access to innovative solutions.

Among the objectives

• To work on the study and updating of the chemical exposome.
• To make the chemical exposome and its impact on health known to health and non-health professionals through continuous training.
• To intervene in community training.
• To contact members of other working groups, scientific societies, public and private entities for collaboration and joint work in relation to our training and research objectives.

The EEN2EIC (Enterprise Europe Network to European Innovation Council) project aims to extend the breadth of supporting activities EEN can provide to women entrepreneurs, widening countries and Seal of Excellence (SoE) holders. The goal is to create a bridge between the two projects in order to support innovation, scale up companies and involve the most relevant actors in the EIC and EEN landscape.

Proposals for IDEA² were invited from anywhere in the world, and selected teams come from Sweden, Spain, Chile, Argentina, Poland, and the United States. IDEA² program contributors for the 2024 edition include the MIT Institute for Medical Engineering and Science (IMES), the MIT Deshpande Center, the Medicine Innovation Program at Massachusetts General Hospital, the US Department of Veterans Affairs, Boston Landing, and MIT Hacking Medicine. 

The congress will take place at the Hotel Iruña Park from 9:00h until 14:30h.

The opening of the congress will have the presence of the MEP Da Ma Eugenia Palop (online or in person) and the MEP Da Adriana Maldonado, the act will be presented by Do Vicente Navarro, Da Concha Vidaurre and Da María Asun Fernández. The congress is divided in four round tables: Health, Technical, Justice and Social aspects. Different professionals (medical doctors, oncologists, scientitists, architects, lawyers and patients' associations)  will discuss on the #asbestos problem and main advances in the area

BIOSPAIN is one of the leading conferences in Europe that brings together more than 850 innovative organizations working in health, sustainable agri-food and solutions to climate change. More than 1,500 professionals from 30 countries are taking part in this event, with more than 200 exhibitors and more than 50 investors. AseBio expects to hold more than 3,500 one-on-one meetings during these days. The congress will have an exhibition space, about 40 conferences on various topics, company presentations and networking activities.

The main objective of this event is to promote innovation, investment, collaboration and new business opportunities in the European biotechnology field.

Through workshops, plenary sessions, oral abstracts, poster sessions, and other events, this meeting will  offer plenty of networking opportunities with leading scientists and researchers, and also with patients and their associations. The resulting stimulating ideas will help to establish research collaborations and to fund projects.  This year iMig Conference is in France on summer 2023.

VENUE:
Auditorium of the Official College of Physicians of Barcelona. Passeig de la Bonanova, 47. 08017. Barcelona. Also online format.

REGISTRATION:
Online form: hFps://is.gd/Jlo5OH
For members of the Societat Catalana de Salut: in person 20€, with lunch 55€,online 10€.
Non-members: presential 80€, with lunch 115€, online 50€.
To become a member: hFps://acortar.link/6HFhY6
The registration fee includes attendance to the activities included in the program, documentation program, documentation, coffee breaks

ORAL PRESENTATIONS:
Abstracts for oral presentations should be sent by March 15, 2023 to the following form March 15, 2023 to the following form: hFp://abstracts.academia.cat/form.php?id=2013

PHOTOGRAPHY CONTEST:
The terms and conditions of the photo contest on the on environmental health can be consulted on the on the web www.socsa.cat

Various sources of exposure to many environmental factors are known, which enter the organism through the digestive, respiratory, dermal and/or percutaneous routes.  One of these polulants is asbestos. Once inside the body it will produce different effects, with varying window periods from the time of exposure. Indeed asbestos-related diseases will have a representation in the meeting with the presentation of Aromics' CEO, Dr. Carme Plasencia.  

Provided recent results of the WHO report confirm that at least 23% of global deaths and 26% of deaths in children under five years of age are due to modifiable environmental factors, the meeting will review different aspects of these diseases and threats for human health.  Please see details of the program here:  PROGRAMA_I Encuentro Internacional de Salud Medioambiental.pdf. 

The eradication of this element, considered a first degree carcinogen and which is present throughout our territory, requires the involvement of multiple sectors: administration, professionals and specialists, citizens and neighborhood movements. Without this joint will, it will not be possible to remove all asbestos in ten years (six in public areas), as indicated in the European guidelines. This convention should serve as a meeting point and a turning point to mobilize all the sectors involved. The convention counts on the presence of doctors and researchers from the medical community, professionals with expertise in the treatment of ACM, lawyers who will discuss the legal framework that we must provide and social movements that are witnesses of the deadly consequences of asbestos will be present.
In order to guarantee the highest level and richness in the debate, we are planning the presence of several speakers from other countries. The objective of the Convention is to influence the administration and the different levels of our society to assume with determination the total eradication of asbestos. The Convention will conclude with the reading of a manifesto where the main challenges to overcome will be marked, such as the immediate need to have a correct census of asbestos, the provision of infrastructures sized to adequately accommodate the waste of the more than 4.2 million tons of asbestos cement estimated to exist in Catalonia and the approval without further delay of the National Plan for the Eradication of Asbestos with its corresponding economic allocation.

he Insud Pharma group has announced the winners of the V edition of its ChemoStart programme. The biotech companies Aromics and MiMark Diagnostics, based in the Barcelona Science Park, together with AntalGenics, a spin-off from the Miguel Hernández University of Elche, have been the three award-winning companies, from among the 12 shortlisted startups who participated in Pitch Day before an external jury made up of different health leaders.

The ChemoStart programme, which seeks to promote innovative and disruptive solutions that improve people’s health and well-being, is led by Leandro Sigman, and it has received the support of the Secretary General for Innovation, Teresa Riesgo. ChemoStart offers the winning startups a support programme which is tailored to their own specific needs. Each project is allocated a designated project manager to provide specific support on commercial processes, intellectual property, marketing and manufacturing, among other areas.

Aromics is one of the companies invited to the pitching session with biotech and pharma start ups will be open to investors and summit attendants in a double format, on site and on-line.  Dr. Carme Plasencia,  co-founder and CEO of Aromics will be presenting the innovative solution  for the treatment of malignant mesothelioma, developed inside Bermes Project supported by the  EU Horizon 2020 SME instrument program. The company will pitch in front of  a panel of qualified investors.

The accelerator has selected, after six pitch forums in 2020, the top 40 companies in the ranking, including AROMICS and its BERMES project. Invest Horizon Accelerated companies have raised more than €53M in 2019 and 2020, with a success rate of 25%.  All startups were evaluated by more than 150 investors during the pitch events on the following criteria: 1. Management experience; 2. Product/technology merit; 3. Market potential; 4. Go to Market/Strategy; Competitive position; 5.

Discover the highest scoring companies from the 2020 Pitching Forums ➡️ https://lnkd.in/eyx7PTu

The award recognizes the efforts and contributions to equal investment opportunities for innovative companies led by women and women-led venture capital funds. It also aims to recognize efforts to reduce the investment equality gap for women, and to change the status-quo as a woman investor and as a Venture Capitalist, and to create a different decision-making process. At the same time, it is a recognition of women entrepreneurs in the field of innovation like Dr. Plasencia who are driving change in our society with their innovative technologies and solutions in the field of sustainability, advanced technology and digitalization.  This year, Mrs Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth,  confirmed her participation in the award ceremony on 9 December at 4.30 p.m.

Congratulation to all winners and finalists!

Our CEO, Dr. Carme Plasencia, the pulmonologist Josep Tarrés, and the engineer Lara Trujillo have participated in this debate in which they have underlined the importance of "making the public aware of the danger it represents", for the population.

Futbol Club Barcelona hosts a meeting of female entrepreneurs and managers to explain the women's football project and to promote the role of women in sport. More than 70 businesswomen, amongst them our CEO Carme Plasencia and Catalan managers have visited this Saturday the facilities of the Ciutat Esportiva of FC Barcelona and the Johan Cruyff Stadium, where they have been able to know first hand the project of the Women's Barça.

The TMB Foundation has organised an exhibition to explain the measures that the TMB company has taken to eliminate asbestos from the Barcelona metro, from which it has already removed 108.7 tonnes of this material potentially fatal to health.

The exhibition, "La lluita contra l'amiant" (The fight against asbestos), can be seen until mid-January in the Espai Mercè Sala, in the Diagonal metro station, and is being organised after TMB has recognised that 27 active underground workers have some form of pleural affectation related to exposure to this material.

The company will remain closed from 24th December 2019 until 2nd January 2020. 

On the 15th November 2019, the first scientific working session on asbestos and its consequences in health will take place. It is a scientific day aimed to discuss about different aspects of the diseases directly associated to the exposure to fibres of the mineral, nowadays considered as a first level carcinogenic material by the World Health Organization.

We will provide an overview of different  translational and clinical research lines in malignant mesothelioma as well as about new initiatives for the generation of novel therapies to treat this cancer. Below, the information related to the workshop:

- Respiratory diseases linked to asbestosis

Dr. Josep Morera Prat - Co-director of the Servei Respiratori Centre Mèdic Teknon

- Malignant pathology in a population exposed to asbestos. The case of Cerdanyola - Ripollet

Dr. Josep Tarrés Olivella - Coordinator of the Observatory Medical Team for the Study of Pathologies Related to Asbestos in Vallès Occidental

- Update on diagnosis and treatment of malignant pleural mesothelioma

Dr. Ernest Nadal Alforja - Cap de Secció de Tumors Toràcics i de Cap i Coll. Medical Oncology. Catalan Institute of Oncology. L'Hospitalet.

-BERMES Project: Development of a new drug for malignant mesothelioma

Dr. Carme Plasencia Castillo - Scientific Director of AROMICS

The conference will take place from 12:00 to 14:00h at the Antoni Caparrós Auditorium of the Barcelona Science Park (c/ Baldiri Reixac 4-12, Barcelona).

The conference is the main destination for meetings for industry professionals and academics to explore the rapid advance of mRNA science and therapeutic and diagnostic applications, providing participants with a platform to establish contacts with potential collaborators on advances in mRNA technology and to attend scientific presentations by the most relevant experts in the field

The 2019 SIWHT is a high-level international event aims to establish communication platforms for European and Chinese healthcare technology entrepreneurs and investors to integrate into China innovation ecosystems and market, and furthermore, to explore possibilities to set up business in China and benefit from the growth of Chinese economy.

Dr. Plasencia will be one of the companies of the Catalan Bioregion lead by BIOCAT. During the conference, AROMICS will present recent advances in its EU-funded project BERMES project, looking for attraction of partners, pharma collaborators and investment to advance the product up to clinics.

2nd META-CAN Workshop was hosted by Leuven University from 23rd September 2019. A selected group of outstanding speakers in the fields of mouse models in cancer research, organomimetic models and bioinformatics. Talks will include both basic and applied/translational research.

The event took place at the Thermotechnical Institute in Heverlee, Leuven University, from 23rd to 26th September 2019.

The company had the opportunity to  meet top-tier European SMEs and introduce BERMES project results, as well as other like-minded entrepreneurs and discuss how to tackle the financing gaps for SME.